/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Margherita Rimini

Vita-Salute San Raffaele University(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

160

Papers

2.2K

Citations

25

h-index

62

i10-index

Margherita Rimini is an academic researcher from Vita-Salute San Raffaele University. The author has contributed to research in topics: Cholangiocarcinoma and Gallbladder Cancer Studies & Hepatocellular Carcinoma Treatment and Prognosis & Gallbladder and Bile Duct Disorders. The author has an h-index of 25, co-authored 136 publications.

ORCID: 0000-0002-4047-2585

Research Topics

Cholangiocarcinoma and Gallbladder Cancer Studies Hepatocellular Carcinoma Treatment and Prognosis Gallbladder and Bile Duct Disorders Pancreatic and Hepatic Oncology Research Colorectal Cancer Treatments and Studies

Papers by this author

works

Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

2023 · Liver International · 110 citations

https://doi.org/10.1111/liv.15641

Margherita Rimini Lorenzo Fornaro Sara Lonardi Monica Niger

The A.L.A.N. score identifies prognostic classes in advanced biliary cancer patients receiving first-line chemotherapy

2019 · European Journal of Cancer · 25 citations

https://doi.org/10.1016/j.ejca.2019.05.030

Massimiliano Salati Francesco Catanzariti David Cunningham Luigi Marcheselli

Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus Bevacizumab

2024 · Targeted Oncology · 7 citations

https://doi.org/10.1007/s11523-024-01061-0

Mara Persano Margherita Rimini Toshifumi Tada Goki Suda

Efficacy of cisplatin-gemcitabine-durvalumab in patients with advanced biliary tract cancer experiencing early vs late disease relapse after surgery: a large real-life worldwide population

2024 · The Oncologist · 7 citations

https://doi.org/10.1093/oncolo/oyae256

Federica Lo Prinzi Francesca Salani Margherita Rimini Mario Domenico Rizzato

The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT

2022 · Journal of Gastrointestinal Cancer · 5 citations

https://doi.org/10.1007/s12029-022-00850-y

Margherita Rimini Pierfrancesco Franco Federica Bertolini De Bari Berardino

Efficacy and Safety of Lenvatinib Versus Sorafenib in Recurrent HCC After Liver Transplant: A Multi‐Center Real‐World Study

2025 · Hepatology Research · 1 citations

https://doi.org/10.1111/hepr.70076

Federica Lo Prinzi Federico Rossari Antonio De Rosa Caterina Vivaldi

Research topics

topics

Cholangiocarcinoma and Gallbladder Cancer Studies

Hepatocellular Carcinoma Treatment and Prognosis

Gallbladder and Bile Duct Disorders

Pancreatic and Hepatic Oncology Research

Colorectal Cancer Treatments and Studies

Chat about Author

Papers

Chat

Click to start Chat